Articles with public access mandates - Peter J. SnyderLearn more
Not available anywhere: 9
APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease
YY Lim, VL Villemagne, RH Pietrzak, D Ames, KA Ellis, K Harrington, ...
Neurobiology of aging 36 (3), 1239-1244, 2015
Mandates: National Health and Medical Research Council, Australia
Amyloid-β related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults
S Hollands, YY Lim, R Buckley, RH Pietrzak, PJ Snyder, D Ames, KA Ellis, ...
Journal of Alzheimer's Disease 43 (2), 677-686, 2015
Mandates: National Health and Medical Research Council, Australia
Double-Blind Crossover Study of the Cognitive Effects of Lorazepam in Healthy Apolipoprotein E (APOE)-ε4 Carriers
CM Stonnington, PJ Snyder, JG Hentz, EM Reiman, RJ Caselli
The Journal of clinical psychiatry 70 (10), 4746, 2009
Mandates: US National Institutes of Health
Sensitivity of a Preclinical Alzheimer’s Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer’s disease
L Bransby, YY Lim, D Ames, C Fowler, J Roberston, K Harrington, ...
Journal of clinical and experimental neuropsychology 41 (6), 591-600, 2019
Mandates: National Health and Medical Research Council, Australia
Episodic memory and learning dysfunction over an 18-month period in preclinical and prodromal Alzheimer’s disease
JE Baker, YY Lim, J Jaeger, D Ames, NT Lautenschlager, J Robertson, ...
Journal of Alzheimer's Disease 65 (3), 977-988, 2018
Mandates: National Health and Medical Research Council, Australia
Performance on the cogstate brief battery is related to amyloid levels and hippocampal volume in very mild dementia
YY Lim, VL Villemagne, SM Laws, RH Pietrzak, D Ames, C Fowler, ...
Journal of Molecular Neuroscience 60, 362-370, 2016
Mandates: National Health and Medical Research Council, Australia
Short term stability of verbal memory impairment in mild cognitive impairment and Alzheimer's disease measured using the International Shopping List Test
YY Lim, K Harrington, D Ames, KA Ellis, R Lachovitzki, PJ Snyder, ...
Journal of Clinical and Experimental Neuropsychology 34 (8), 853-863, 2012
Mandates: National Health and Medical Research Council, Australia
APOE ɛ4 genotype, amyloid, and clinical disease progression in cognitively normal older adults
S Hollands, YY Lim, SM Laws, VL Villemagne, RH Pietrzak, K Harrington, ...
Journal of Alzheimer's Disease 57 (2), 411-422, 2017
Mandates: National Health and Medical Research Council, Australia
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease
A Cannizzaro, L Ronat, LM El Haffaf, A Hanganu, ADNI, M Weiner, ...
International journal of geriatric psychiatry 38 (6), e5952, 2023
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
Available somewhere: 91
The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic …
MS Albert, ST DeKosky, D Dickson, B Dubois, HH Feldman, NC Fox, ...
Focus 11 (1), 96-106, 2013
Mandates: US National Institutes of Health
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
H Hampel, MM Mesulam, AC Cuello, MR Farlow, E Giacobini, ...
Brain 141 (7), 1917-1933, 2018
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
The Alzheimer's disease neuroimaging initiative: progress report and future plans
MW Weiner, PS Aisen, CR Jack Jr, WJ Jagust, JQ Trojanowski, L Shaw, ...
Alzheimer's & Dementia 6 (3), 202-211. e7, 2010
Mandates: US National Institutes of Health
Plasma tau in Alzheimer disease
N Mattsson, H Zetterberg, S Janelidze, PS Insel, U Andreasson, ...
Neurology 87 (17), 1827-1835, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
In vivo staging of regional amyloid deposition
MJ Grothe, H Barthel, J Sepulcre, M Dyrba, O Sabri, SJ Teipel, ...
Neurology 89 (20), 2031-2038, 2017
Mandates: US Department of Defense, US National Institutes of Health, Canadian …
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
S Palmqvist, H Zetterberg, N Mattsson, P Johansson, ...
Neurology 85 (14), 1240-1249, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Practice effects due to serial cognitive assessment: implications for preclinical Alzheimer's disease randomized controlled trials
TE Goldberg, PD Harvey, KA Wesnes, PJ Snyder, LS Schneider
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (1 …, 2015
Mandates: US National Institutes of Health
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
Mandates: US National Institutes of Health, Australian Research Council, National …
Revisiting the cholinergic hypothesis in Alzheimer’s disease: emerging evidence from translational and clinical research
H Hampel, MM Mesulam, AC Cuello, AS Khachaturian, A Vergallo, ...
The journal of prevention of Alzheimer's disease 6, 2-15, 2019
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly
AJ Ho, JL Stein, X Hua, S Lee, DP Hibar, AD Leow, ID Dinov, AW Toga, ...
Proceedings of the National Academy of Sciences 107 (18), 8404-8409, 2010
Mandates: US National Institutes of Health
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
TW Schmitz, R Nathan Spreng
Nature communications 7 (1), 13249, 2016
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
Publication and funding information is determined automatically by a computer program